Thus, dietary or interventional strategies to reduce blood lipids and increase saturated fatty acid intake could further improve the anti‐tumour effectiveness of SCD1 inhibition‐based treatments for several cancers, including ovarian cancer, characterised by frequent overexpression and amplification of CARM1. Here, CARM1 is linked to ovarian cancer.